Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics

The approved worldwide use of two messenger RNA (mRNA) vaccines (BNT162b2 and mRNA-1273) in late 2020 has proven the remarkable success of mRNA therapeutics together with lipid nanoformulation technology in protecting people against coronaviruses during COVID-19 pandemic. This unprecedented and exci...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wei, Cao, Jianwei, Cheng, Hui, Chen, Liang, Yu, Meihua, Chen, Yu, Cui, Xingang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712057/
https://www.ncbi.nlm.nih.gov/pubmed/36471724
http://dx.doi.org/10.1016/j.bioactmat.2022.11.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712057/
https://www.ncbi.nlm.nih.gov/pubmed/36471724
http://dx.doi.org/10.1016/j.bioactmat.2022.11.014

Ejemplares similares